Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
Because of differential processing of the hormone precursor, proglucagon, numerous peptide products are released from the pancreatic alpha cells and the intestinal L-cells in which the (pro)glucagon gene is expressed. Of particular interest in relation to obesity are glucagon from the pancreas and o...
Main Author: | Jens Juul Holst |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2022.964406/full |
Similar Items
-
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
by: Jens Juul Holst
Published: (2019-04-01) -
Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals
by: David M. Irwin, et al.
Published: (2021-07-01) -
Mutational Landscape of the Proglucagon-Derived Peptides
by: Peter Lindquist, et al.
Published: (2021-06-01) -
Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health
by: Robert Wagner, et al.
Published: (2022-06-01) -
A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon‐derived peptide levels
by: Masaki Kobayashi, et al.
Published: (2023-05-01)